The average time from the start of EGFR-TKI treatment to the onset of cutaneous vasculitis is 8.7 ± 7.8 weeks, with a range of 1 week to 8 months, indicating that clinical manifestations and signs may have a delayed onset. This evidence concerns the gene EGFR and cutaneous vasculitis.